{"name":"Lexaria Bioscience Corp.","slug":"lexaria-bioscience-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Arm 2 - DehydraTECH-semaglutide alone","genericName":"Arm 2 - DehydraTECH-semaglutide alone","slug":"arm-2-dehydratech-semaglutide-alone","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Arm 5- Tirzepatide","genericName":"Arm 5- Tirzepatide","slug":"arm-5-tirzepatide","indication":"Type 2 diabetes","status":"phase_1"}]}],"pipeline":[{"name":"Arm 2 - DehydraTECH-semaglutide alone","genericName":"Arm 2 - DehydraTECH-semaglutide alone","slug":"arm-2-dehydratech-semaglutide-alone","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Arm 5- Tirzepatide","genericName":"Arm 5- Tirzepatide","slug":"arm-5-tirzepatide","phase":"phase_1","mechanism":"GLP-1 receptor agonist","indications":["Type 2 diabetes","Obesity"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPNHNiSTBUMkJGNF9tVm1ja3N5ZVFybEFtRVBPdDJ3VzhhVXZqbWhoaUxsRVNmLW1FbkNVb3MxcV9lSVNlUXFXT00zM1lPYTNqT1lKZFJFdTJwM29Iek8zOFYxdklkWXBtMTY2MlVteDFqTE5lcTh6V1I1WVJ5ZzZRTVExVXBobXgteXVpQTIwakVwb041bnJXaHd0a0dYNG45akZRdHZjVkpoejctcktZ?oc=5","date":"2026-04-03","type":"pipeline","source":"Sahm","summary":"12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm","headline":"12 Health Care Stocks Moving In Thursday's Intraday Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNZ2wzMHUwSkVGMk5xSklSS3JSQWt5ZERhanNiQ1FFT0taenhmb3JPOGVvS2V2RVdxWTUyQU9mS3plSXpsZk5jV3RfVkJuakMxNE9GdlZ5aWFkOGNzXzJMYUZqbjk0dWpSRzZUaWNuNjFzOWRHd0xiUHM4V3VuRlRwSlByTHJHTmhSbHJlc1FQZTV0cFMtVDRwbEN4ZU40S0FkY2l6UDNqdzFyQmRsaUE?oc=5","date":"2026-03-24","type":"deal","source":"Investing.com","summary":"Lexaria pursues oral GLP-1 drug delivery partnerships - Investing.com","headline":"Lexaria pursues oral GLP-1 drug delivery partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPdXNaQWdSbUVrelZ3U3dPUWlFWWoxOC1RbXZSZl8zNlBxd0FENXlnX2hvVWFGUFVuNkNDOEIxVlAzRnZMMWxWSEIwRGVxdHNEVHN3b1dLTjNWMUdabVo4THNjMURrMktWTDFJaFloTHVMMGN0c3B0cE9ERm9RZU8yWE5vbkZESUJwLVNlbWNwSlJucW50ajgtV193VWlUZExEd2QtOGhxY3Jwa09EWEtKakNjeW1ha293aF9XV01IeUZ5UXUxdnVMYVowWURJa2plZmdaM1Zja0p6V0JFT3dOYUhR?oc=5","date":"2026-03-24","type":"pipeline","source":"Corsicana Daily Sun","summary":"Lexaria's Oral GLP-1 Drug Strategy Validated by Industry - Corsicana Daily Sun","headline":"Lexaria's Oral GLP-1 Drug Strategy Validated by Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOS2JPZnIxQkR6d1BpRjF1dkZzeG1xbG9tQllOVTRzeVd0LXZ1OENUbGY3Y2tCcTJjbHZ6Q1pHZXI4R2RSSGZkaDUxbWpHN2JIVE5PamNCX3JHUXpiWXFWcndDTV95UF9ZTWs2NTlxWVpXellHendxR3lfU1ZOOWhRQ2hZX082cDg0bmw2N25JTjY3dVNBc3IxVVpwUnpHQVlNZDdrSQ?oc=5","date":"2026-03-24","type":"pipeline","source":"Stock Titan","summary":"Weight-loss pills over shots? Lexaria says pharma talks are underway - Stock Titan","headline":"Weight-loss pills over shots? Lexaria says pharma talks are underway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9LQ3RjYURIQlZ4SExsRWYwa0FxUnN1a1czUlAzMWc5SVdFT09ERnMzNHlhMzBjN05NR2JvRmpBQjZZSk1RUG5tUGhGM0RUSWFMRngtbVhYWW00bk1nWVHSAWNBVV95cUxPU19fcE5NVU1XS2ZBM1FSOHl1cnRwU09iZzNGVWtmejY0ZE9NVW45cTI0RUw0Wmt4RDA3YktBaHlJejBXbFZ0ejdhOHZnTzB1SDRfWUJIRjdiVG9qV2VDOVhTYms?oc=5","date":"2026-03-24","type":"pipeline","source":"Bitget","summary":"Lexaria's Oral GLP-1 Drug Strategy Validated by Industry - Bitget","headline":"Lexaria's Oral GLP-1 Drug Strategy Validated by Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1ONmoxQmREeTRpbnZNbU1PT3ZPR285VkczQmN0TkNTbGprLV9fU1RmaW5TMWhWQzBaZ01qNTNrUWhuN2dLTzJvM1ZmUFVqWjlUcEU3dEdpYS1CQjNnZVF0Z1lvcGxSUzFjY25ESV9B?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Lexaria Bioscience Corp (LEXX) - Stock Titan","headline":"If You Invested $1,000 in Lexaria Bioscience Corp (LEXX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1McENMTmlOMTdRcEtNMGtkcXU1M3BzUWtDb1o5eWFabmprNm9TdkNieXd3WGRxZm9wVnZBNmRRckhMMFBzdzJHb0RBTk5pczhUUjNLVl9ZaFJCV3dvZjJpMThOUlNVMlFCX1YzajNyN1BLako3?oc=5","date":"2026-03-04","type":"pipeline","source":"Investing News Network","summary":"Lexaria Announces New R&D Plans for 2026 - Investing News Network","headline":"Lexaria Announces New R&D Plans for 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPQ1JWYlkyVWRnX0JNOHQ4eTBIaVRFLTBaZEFPQ1J4b3Jld28ySGdqNk0zLUNkQnAyREZzNVVmd3d2eElQWkFQbHpvV2tqMG9CaXREZzl6NFV6TXhXSnNMZ29YTUo4dFJra2ktdk1uRnBuUFZGTVVDeDBObE9fWTJWN3pwNUp4bXR4Q3I1VzYyTG03bDJwT0FQZWdIUjU1dUZIcTBINnVtbHU5c3NNclBXX1dNbEZwdUNDN1YyTTc4YmdFR05pSmRtdlEyTUhUMlptZm9j?oc=5","date":"2026-01-12","type":"regulatory","source":"Benzinga","summary":"Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1ZU3JQQlFNQVJmdmdkWm5GYUVBM2NQc1FZdEJjNzZfaUhVVVp3bEl5RzZpYV82OWpLV1ROd2JPWHZFaHBycW5QbzYwX2lQdlA4c0dydXE3c3IxXzRVTjVESmYtUGhObTNhRGFLVkdrOA?oc=5","date":"2025-09-29","type":"pipeline","source":"TradingKey","summary":"Healthcare Sector: Companies, Performance and Stocks - TradingKey","headline":"Healthcare Sector: Companies, Performance and Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFA5Y2c5R0hCSmRZeW1WMnd1RENIVUFBd0JvWHJWbEtnSWh3VzZraFV6VTJnU3dnSlRiWDBRNXJJaDRNYWsxcVB6Y2xmTXpHRXMtNjlWT3dXWXNwbTFxa2phcUdpUzlTZnFi?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Lexaria Bioscience (LEXX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $LEXX - MarketBeat","headline":"Lexaria Bioscience (LEXX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $LEXX","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-03-21","type":"pipeline","source":"simplywall.st","summary":"Here's Why We're Watching Lexaria Bioscience's (NASDAQ:LEXX) Cash Burn Situation - simplywall.st","headline":"Here's Why We're Watching Lexaria Bioscience's (NASDAQ:LEXX) Cash Burn Situation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPS0tUU1BhX0xFd3dySmxsdEZpcEVaaHl1NV85TnlQRkZ0WFMzNTFaRW4wYXhPNGRTNVdPS3lGUDFudnkwdDMzaVdiNmt2QXFZdHFWY2dUTU1MOTBGc0tDQ0JnVHAyWElYeVl1RmoyMWJEbXF1azJkdzd3MVJXQUNGVW1Zc0lGQXlJTWE1SnZzSldvaGxTWG1fbnpwdVZfWjk2anRCVmExcmR2aGJiTG1pdzR2M0k4c3M3SUV2VERXQVViM2taNm53VVNQejQ4bVcxWnU1aUZpdmlXVTZ1OEhtczA3WXE?oc=5","date":"2024-03-18","type":"pipeline","source":"Proactive financial news","summary":"Lexaria Bioscience Revolutionizes Drug Delivery with DehydraTECH for GLP-1 drug - Proactive financial news","headline":"Lexaria Bioscience Revolutionizes Drug Delivery with DehydraTECH for GLP-1 drug","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}